These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21665399)

  • 1. Identification and control of impurities in streptomycin sulfate by high-performance liquid chromatography coupled with mass detection and corona charged-aerosol detection.
    Holzgrabe U; Nap CJ; Kunz N; Almeling S
    J Pharm Biomed Anal; 2011 Sep; 56(2):271-9. PubMed ID: 21665399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of impurities in streptomycin and dihydrostreptomycin by hydrophilic interaction chromatography/electrospray ionization quadrupole ion trap/time-of-flight mass spectrometry.
    Kawano S
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):907-14. PubMed ID: 19224534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, synthesis and quantification of process-related impurities in auraptene.
    Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
    J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of impurities in L-aspartic acid and L-alanine by high-performance liquid chromatography coupled with a corona charged aerosol detector.
    Holzgrabe U; Nap CJ; Almeling S
    J Chromatogr A; 2010 Jan; 1217(3):294-301. PubMed ID: 19954785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impurity profiling of micronomicin sulfate injection by liquid chromatography-ion trap mass spectrometry.
    Yuan YZ; Zhao X; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():94-104. PubMed ID: 23261805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive impurity profiling of nutritional infusion solutions by multidimensional off-line reversed-phase liquid chromatography × hydrophilic interaction chromatography-ion trap mass-spectrometry and charged aerosol detection with universal calibration.
    Schiesel S; Lämmerhofer M; Lindner W
    J Chromatogr A; 2012 Oct; 1259():100-10. PubMed ID: 22284534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
    Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of macrolide antibiotic residues in eggs, raw milk, and honey using both ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry and high-performance liquid chromatography/tandem mass spectrometry.
    Wang J; Leung D
    Rapid Commun Mass Spectrom; 2007; 21(19):3213-22. PubMed ID: 17768705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an enhanced separation of erythromycin and its related substances by liquid chromatography.
    Deubel A; Holzgrabe U
    J Pharm Biomed Anal; 2007 Jan; 43(2):493-8. PubMed ID: 16935448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry.
    Grahek R; Zupancic-Kralj L
    J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
    Kasawar GB; Farooqui M
    J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of streptomycin residues in honey by liquid chromatography-tandem mass spectrometry.
    Granja RH; Niño AM; Zucchetti RA; Niño RE; Patel R; Salerno AG
    Anal Chim Acta; 2009 Apr; 637(1-2):64-7. PubMed ID: 19286013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of neomycin and related substances in pharmaceutical preparations by reversed-phase high performance liquid chromatography with mass spectrometry and charged aerosol detection.
    Stypulkowska K; Blazewicz A; Fijalek Z; Warowna-Grzeskiewicz M; Srebrzynska K
    J Pharm Biomed Anal; 2013 Mar; 76():207-14. PubMed ID: 23337822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric characterization of gentamicin components separated by the new European Pharmacopoeia method.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2011 Apr; 55(1):78-84. PubMed ID: 21316176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of unknown related substances in commercial neomycin samples with liquid chromatography/ion trap tandem mass spectrometry.
    Li B; Van Schepdael A; Hoogmartens J; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(11):1791-8. PubMed ID: 17486672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.